SHA:600332 Revenue

Guangzhou Baiyunshan Pharmaceutical Holdings Company had revenue of 22.47B CNY in the quarter ending March 31, 2025, a decrease of -2.06%. This brings the company's revenue in the last twelve months to 74.52B, down -3.01% year-over-year. In the year 2024, Guangzhou Baiyunshan Pharmaceutical Holdings Company had annual revenue of 74.99B, down -0.69%.

Revenue (ttm)

74.52B

Revenue Growth

-3.01%

P/S Ratio

0.54

Revenue / Employee

2.65M

Employees

28,048

Market Cap

40.59B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	74.99B	-522.58M	-0.69%
Dec 31, 2023	75.52B	4.73B	6.68%
Dec 31, 2022	70.79B	1.77B	2.57%
Dec 31, 2021	69.01B	7.34B	11.90%
Dec 31, 2020	61.67B	-3.28B	-5.05%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Jan 1, 2018	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	39.59B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Aier Eye Hospital Group	21.81B
Sichuan Biokin Pharmaceutical	5.82B
Shanghai United Imaging Healthcare	10.43B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings